Redefine just proved the boring version of property works. Distributable income up 7.5% to R3.9 billion, dividend up 7% to 49.06 cents, and a 77% net operating margin that most landlords can only dream about. The balance sheet did the heavy lifting: loan-to-value down to 38.8%, R7.3 billion of undrawn facilities and cash, and property assets of R102.1 billion. Yes, HEPS nearly doubled to 72.97 cents, but don't get excited about that number - it's a valuation and impairment swing, not a rent miracle. The dividend is the truth, and the dividend grew 7%.
At R6.31 you're buying a 7.8% yield, 26% below the R8.58 net asset value, with management guiding 3-5% distribution growth for FY27 and a fat 87.5% payout. The Polish joint venture simplification and the recycling of non-core assets are the right moves - less complexity, lower cost of capital. Higher-for-longer rates will keep the share price tied to the bond market, so this isn't a quick trade. It's an income buy for people who like being paid to wait. I'll take that side of the argument.
Mantengu has been a cautionary announcement with a share listing attached for months. The proposed acquisition of Averi Finance assets - and the reverse takeover that came with it - was the entire investment case. Today it was terminated by mutual agreement, with the company saying it needs to finish a review of its investment portfolio and 'optimise' its chrome and platinum operations. The parties may re-engage in 2027. That's not a deal, that's a maybe with a one-year delay.
The shares sit at 17 cents and are down 10.5% in a month, and this announcement removes the only catalyst that could have re-rated them. What's left is a small chrome and platinum operator in a market where small chrome and platinum operators are ten a penny, plus a strategic review that historically ends one of two ways: a discounted capital raise or another disposal. Could something be salvaged in 2027? Sure. But you're now holding a 17 cent shell on a promise to think about it next year. Sell the hope, buy the assets when someone actually pays for them. Bearish.
For two years MTN's Nigerian operation was the reason to avoid the share. Naira devaluation, tower costs, a regulator with an appetite for fines - it was one long apology. That's over. Nine-month service revenue up 23.7% to N4.6 trillion, with Q3 accelerating to 19.7% and each month of the quarter faster than the last - 21.6% by September. EBITDA up 36.8% to N2.6 trillion, margin 56.9%. Profit after tax up 55.3% to N1.2 trillion. Free cash flow up 57.5% to N1.2 trillion. That last number is the one that pays dividends and funds the towers.
Subscribers are up 10.9% to 94.7 million and data users up 12% to 57.2 million. But the sneaky good line is fintech: core mobile money revenue more than doubled, up 102.2%, and the airtime and data credit business is up 78.5% on the previous quarter after the multi-partner reset. Management reaffirmed guidance - low-20s revenue growth, mid-to-high-50s EBITDA margin - which means the second half doesn't need heroics. MTN at R198 is up 8% in a month and still trades well below where it sat before the naira crisis. Nigeria is fixed. The market is slowly working it out.
Invicta sells bearings, hydraulics and industrial kit into mining, agriculture and construction. When those customers stop spending, Invicta feels it first and hardest. This trading statement is ugly: HEPS of 189 to 199 cents against 265 cents, a fall of 25% to 29%. EPS down 15% to 21%. That's not a wobble, that's a proper earnings hit, and it follows a period where the market was already marking the stock down.
Management has done the standard dance: "challenging macroeconomic environment", measures already implemented, "full benefits expected in the next financial year". I've read that sentence a hundred times and it usually means another six months of pain before anything improves. The shares at R33.50 aren't expensive on normalised earnings, and Invicta's balance sheet is sound - this isn't a solvency story. But you don't buy a cyclical on the way down just because the multiple looks low, and there's no evidence yet that the industrial cycle has turned. Wait for the 23 November results and, more importantly, for the first half of FY28 to prove the fixes worked. Bearish.
This is the permit Gold Fields has been waiting for, and the market barely blinked. Quebec's environment ministry issued the Certificate of Authorisation for Windfall on 30 October, completing the environmental and social impact assessment and clearing the way for construction and full project development. It follows the Uukiimau Agreement signed with the Cree Nation of Waswanipi in June - so the social licence and the regulatory licence are both in hand. Windfall is one of the highest-grade gold projects in Canada, with roughly 300,000 ounces a year expected once ramped up and real growth potential along strike and down plunge.
The next milestones are concrete: site activities restart, early civil works and camp construction begin, and by February 2027 - with the 2026 provisional results - Gold Fields publishes the updated construction schedule, capital estimate and the Windfall resources and reserves. The final investment decision follows board approval. Anyone who has watched a Canadian mine permit process knows this is the hard part done. Gold at $3,970 and Gold Fields down 6.6% in a month tells you the market is focused on the gold price, not the pipeline. That's the mispricing: a 300,000 ounce a year asset just moved from 'maybe' to 'build'. Bullish.
Exemplar owns 31 shopping centres in places most fund managers couldn't find on a map - and that's precisely the moat. Revenue up 13.8% to R847 million, net property income up 13%, interim dividend up 6.7% to 90.58 cents, and net asset value up 15.7% to R19.75 a share. Headline earnings per share fell 6.9% to 68.39 cents, but that's an accounting wrinkle around the prior year's fair value gains; the cash distribution - the only number a REIT shareholder should care about - went up.
Management confirmed guidance of 9-11% distribution growth for FY27, which on a roughly 181 cent annual payout means north of 195 cents. The catch is the price. At R24.00, the stock is up 32% in a month and trades at a 21% premium to net asset value. You're paying up for quality in a sector where most peers trade at discounts. That's a fair argument for caution, and if you're buying today you're buying momentum, not value. But a rural, low-LSM retail portfolio with 9-11% distribution growth, in a country where formal retail keeps taking share in the townships, deserves a premium. I'd own it on weakness rather than chase it here - but bullish is the call.
Aspen has spent the last two years telling anyone who'd listen that the sum of its parts is worth more than the whole. This is what that looks like in practice. Ovestin - a women's health product with European commercialisation rights and related IP - goes to Ennogen for EUR197 million in cash, plus roughly EUR4 million for the inventory. At current rand levels that's close to R4 billion for a single product line that sits outside Aspen's core emerging markets focus.
The logic is clean: management says the price represents a strong multiple, the cash gives flexibility, and the proceeds can go to reducing debt or funding the growth assets that actually matter. Aspen has been a serial acquirer for two decades; the interesting shift is that it's now happy to be a seller when the price is right. At R158 the stock is flat over a month, which tells you the market is treating this as housekeeping rather than transformation - and that's fair, one product doesn't move a R70 billion business. But each of these disposals narrows the discount and sharpens the story. If Aspen keeps selling non-core assets at these multiples, the sum-of-the-parts argument stops being a slide in a presentation and starts being cash in the bank. Bullish.
Altron spent years being the JSE's favourite restructuring story. This set of numbers says the restructuring is done and the business is now just... good. Revenue up 5% to R5.1 billion, the strongest interim growth in three years. EBITDA up 16% to R1.1 billion with the margin 210 basis points better at 21.5%. HEPS up 14% to 109 cents. Interim dividend up 15% to 55 cents, a 50% payout, after already handing shareholders R755 million in June. And the balance sheet still closed with over R800 million net cash.
The number that matters most is the cash conversion: 92% of EBITDA turned into operating cash, up from 81%. That's the difference between a company that reports profit and one that banks it. Netstar's annuity revenue is now 94% of its revenue and Altron FinTech's operating profit has more than doubled in three years to R300 million. Platforms are over 95% of group operating profit - which is exactly why the Nexus exit and the junk were worth the pain. At R28.52 you're paying about 13 times annualised HEPS for a business growing double digits and paying out half its earnings. Cheap for quality. Bullish.